ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
-0.15%
Bitcoin
67,656.96
0.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pozen, Inc. (MM) (POZN)

  7. Pozen, Inc. (MM) (POZN) News

POZN

Pozen, Inc. (MM) (POZN)

Pozen, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:POZN
DateTimeSourceHeadlineSymbolCompany
15/03/201606:08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:POZNPozen, Inc. (MM)
15/03/201604:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:POZNPozen, Inc. (MM)
15/03/201604:21Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:POZNPozen, Inc. (MM)
20/10/200900:01PR Newswire (US)Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated UlcersASX:POZN
16/10/200923:45Dow Jones NewsAstraZeneca Submits EU Marketing Application For VimovoASX:POZNPozen Inc.
31/08/200922:39Dow Jones NewsPozen Earns $10 Million From AstraZeneca As FDA Accepts Drug ApplicationASX:POZNPozen Inc.
30/06/200922:57Dow Jones NewsAstraZeneca Partner Pozen Submits PN400 New Drug ApplicationASX:POZNPozen Inc.
30/06/200922:57Dow Jones NewsAstraZeneca Partner Pozen Submits PN400 New Drug ApplicationASX:POZNPozen Inc.
09/06/200703:00PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple AttacksASX:POZN
03/05/200705:12PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine AttacksASX:POZN
03/05/200705:09PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine SymptomsASX:POZN
04/05/200607:21PR Newswire (US)American Stock Exchange to Trade Options on Six SecuritiesASX:POZN
 Showing the most relevant articles for your search:NASDAQ:POZN

Your Recent History

ASX
ORG
Origin Energy
FX
AUDCAD
AUD vs CAD
ASX
ANZ
Australia And New Zealan...
ASX
XAO
Australian SE All Ordina...
ASX
MQG
Macquarie
ASX
WBC
Westpac Banking
NASDAQ
GOOGL
Alphabet
ASX
CBA
Commonwealth Bank Of Aus...
ASX
CSL
CSL
ASX
AMP
AMP
NASDAQ
AMZN
Amazon.com
ASX
BHP
BHP
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
ASX
RIO
Rio Tinto
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved